Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease
Gespeichert in:
| Veröffentlicht in: | Experimental Neurology 1997-06, Vol.145 (2), p.309-321 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 321 |
|---|---|
| container_issue | 2 |
| container_start_page | 309 |
| container_title | Experimental Neurology |
| container_volume | 145 |
| creator | Lapchak, Paul A. Gash, Don M. Collins, F. Hilt, Dana Miller, Paul J. Araujo, Dalia M. |
| description | |
| doi_str_mv | 10.1006/exnr.1997.6501 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79131112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488697965018</els_id><sourcerecordid>79131112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-2b21bf3e77dfc4190283ccb66124ae57fac8acfe6e0bbbf5d20e3d814a12e6d03</originalsourceid><addsrcrecordid>eNp1kc1uEzEUhS0EKqF0yw7JC1RgMcH2OPPDLkpIQIpKFu3a8njukAsz9mA7Ufs4fVOcJuqOlaV7vntsn0PIO86mnLHiC9xbP-V1XU6LGeMvyISzmmVC5uwlmTDGZSarqnhN3oTwmzFWS1FekIta8JIV1YQ8bnfaD9q43v1Co3s6NxEPGBECdR1d95hmC-h7ukEL2RI8HqClN7D3Lno37tDQlTbRefppvbxZff5Ktx5Mj_bJbQkH6N04gI1U25bOx7FPQkRnaXQ07oDeetDxCUj3bbX_gzY4-zHQJQbQAd6SV53uA1ydz0tyt_p2u_iebX6ufyzmm8zIXMZMNII3XQ5l2XZG8pqJKjemKQoupIZZ2WlTadNBAaxpmm7WCgZ5W3GpuYCiZfkluT75jt793UOIasBg0s-1BbcPqqx5zjkXCZyeQONdCB46NXoctH9QnKljJ-rYiTp2oo6dpIX3Z-d9M0D7jJ9LSPqHs65DCq3z2hoMz5goC5ZzmbDqhEFK4YDgVTAI1kCLKfGoWof_e8E_SY-qxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79131112</pqid></control><display><type>article</type><title>Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lapchak, Paul A. ; Gash, Don M. ; Collins, F. ; Hilt, Dana ; Miller, Paul J. ; Araujo, Dalia M.</creator><creatorcontrib>Lapchak, Paul A. ; Gash, Don M. ; Collins, F. ; Hilt, Dana ; Miller, Paul J. ; Araujo, Dalia M.</creatorcontrib><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1006/exnr.1997.6501</identifier><identifier>PMID: 9217068</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Animals ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Cell Line ; Glial Cell Line-Derived Neurotrophic Factor ; Humans ; Medical sciences ; Nerve Growth Factors ; Nerve Tissue Proteins - therapeutic use ; Neuroglia - chemistry ; Neuroglia - cytology ; Neuropharmacology ; Neuroprotective Agents - therapeutic use ; Parkinson Disease - drug therapy ; Pharmacology. Drug treatments</subject><ispartof>Experimental Neurology, 1997-06, Vol.145 (2), p.309-321</ispartof><rights>1997 Academic Press</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-2b21bf3e77dfc4190283ccb66124ae57fac8acfe6e0bbbf5d20e3d814a12e6d03</citedby><cites>FETCH-LOGICAL-c434t-2b21bf3e77dfc4190283ccb66124ae57fac8acfe6e0bbbf5d20e3d814a12e6d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/exnr.1997.6501$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,780,784,792,3541,27913,27915,27916,45986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2760314$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9217068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lapchak, Paul A.</creatorcontrib><creatorcontrib>Gash, Don M.</creatorcontrib><creatorcontrib>Collins, F.</creatorcontrib><creatorcontrib>Hilt, Dana</creatorcontrib><creatorcontrib>Miller, Paul J.</creatorcontrib><creatorcontrib>Araujo, Dalia M.</creatorcontrib><title>Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease</title><title>Experimental Neurology</title><addtitle>Exp Neurol</addtitle><subject>Animals</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Glial Cell Line-Derived Neurotrophic Factor</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nerve Growth Factors</subject><subject>Nerve Tissue Proteins - therapeutic use</subject><subject>Neuroglia - chemistry</subject><subject>Neuroglia - cytology</subject><subject>Neuropharmacology</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Parkinson Disease - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1uEzEUhS0EKqF0yw7JC1RgMcH2OPPDLkpIQIpKFu3a8njukAsz9mA7Ufs4fVOcJuqOlaV7vntsn0PIO86mnLHiC9xbP-V1XU6LGeMvyISzmmVC5uwlmTDGZSarqnhN3oTwmzFWS1FekIta8JIV1YQ8bnfaD9q43v1Co3s6NxEPGBECdR1d95hmC-h7ukEL2RI8HqClN7D3Lno37tDQlTbRefppvbxZff5Ktx5Mj_bJbQkH6N04gI1U25bOx7FPQkRnaXQ07oDeetDxCUj3bbX_gzY4-zHQJQbQAd6SV53uA1ydz0tyt_p2u_iebX6ufyzmm8zIXMZMNII3XQ5l2XZG8pqJKjemKQoupIZZ2WlTadNBAaxpmm7WCgZ5W3GpuYCiZfkluT75jt793UOIasBg0s-1BbcPqqx5zjkXCZyeQONdCB46NXoctH9QnKljJ-rYiTp2oo6dpIX3Z-d9M0D7jJ9LSPqHs65DCq3z2hoMz5goC5ZzmbDqhEFK4YDgVTAI1kCLKfGoWof_e8E_SY-qxA</recordid><startdate>19970601</startdate><enddate>19970601</enddate><creator>Lapchak, Paul A.</creator><creator>Gash, Don M.</creator><creator>Collins, F.</creator><creator>Hilt, Dana</creator><creator>Miller, Paul J.</creator><creator>Araujo, Dalia M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970601</creationdate><title>Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease</title><author>Lapchak, Paul A. ; Gash, Don M. ; Collins, F. ; Hilt, Dana ; Miller, Paul J. ; Araujo, Dalia M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-2b21bf3e77dfc4190283ccb66124ae57fac8acfe6e0bbbf5d20e3d814a12e6d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Glial Cell Line-Derived Neurotrophic Factor</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nerve Growth Factors</topic><topic>Nerve Tissue Proteins - therapeutic use</topic><topic>Neuroglia - chemistry</topic><topic>Neuroglia - cytology</topic><topic>Neuropharmacology</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Parkinson Disease - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lapchak, Paul A.</creatorcontrib><creatorcontrib>Gash, Don M.</creatorcontrib><creatorcontrib>Collins, F.</creatorcontrib><creatorcontrib>Hilt, Dana</creatorcontrib><creatorcontrib>Miller, Paul J.</creatorcontrib><creatorcontrib>Araujo, Dalia M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lapchak, Paul A.</au><au>Gash, Don M.</au><au>Collins, F.</au><au>Hilt, Dana</au><au>Miller, Paul J.</au><au>Araujo, Dalia M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease</atitle><jtitle>Experimental Neurology</jtitle><addtitle>Exp Neurol</addtitle><date>1997-06-01</date><risdate>1997</risdate><volume>145</volume><issue>2</issue><spage>309</spage><epage>321</epage><pages>309-321</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>9217068</pmid><doi>10.1006/exnr.1997.6501</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0014-4886 |
| ispartof | Experimental Neurology, 1997-06, Vol.145 (2), p.309-321 |
| issn | 0014-4886 1090-2430 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79131112 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Animals Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cell Line Glial Cell Line-Derived Neurotrophic Factor Humans Medical sciences Nerve Growth Factors Nerve Tissue Proteins - therapeutic use Neuroglia - chemistry Neuroglia - cytology Neuropharmacology Neuroprotective Agents - therapeutic use Parkinson Disease - drug therapy Pharmacology. Drug treatments |
| title | Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A27%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20Activities%20of%20Glial%20Cell%20Line-Derived%20Neurotrophic%20Factor%20(GDNF):%20Preclinical%20Development%20and%20Application%20to%20the%20Treatment%20of%20Parkinson's%20Disease&rft.jtitle=Experimental%20Neurology&rft.au=Lapchak,%20Paul%20A.&rft.date=1997-06-01&rft.volume=145&rft.issue=2&rft.spage=309&rft.epage=321&rft.pages=309-321&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1006/exnr.1997.6501&rft_dat=%3Cproquest_cross%3E79131112%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79131112&rft_id=info:pmid/9217068&rft_els_id=S0014488697965018&rfr_iscdi=true |